⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL62097 | 0.87 | — | — | |
| SCHEMBL56451 | 0.83 | — | — | |
| SCHEMBL3549863 | 0.82 | — | — | |
| SCHEMBL3547597 | 0.82 | — | — | |
| SCHEMBL5510331 | 0.80 | ACE2 (0.48) | — | |
| SCHEMBL5511755 | 0.80 | LMNA (0.43) | — | |
| SCHEMBL9570514 | 0.80 | TSHR (0.33) | — | |
| SCHEMBL20610005 | 0.79 | TSHR (0.59) | — | |
| Ammonia Solution, Strong SCHEMBL8081472 | 0.79 | — | — | |
| SCHEMBL20804038 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105985774-B | The application of nanocrystalline-ligand complex, preparation method, printing material and printing material | 纳晶科技股份有限公司 | 2019-05-28 | — | — | CN | claimed |
| CN-105985774-A | Nanocrystalline-ligand compound, preparation method of nanocrystalline-ligand compound, printing material and use of printing material | 纳晶科技股份有限公司 | 2016-10-05 | — | — | CN | claimed |
| EP-4663693-A1 | METHOD FOR DECOMPOSING COMPOUND | National Institute Of Advanced Industrial Science and Technology (JP) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024166919-A1 | METHOD FOR DECOMPOSING COMPOUND | 国立研究開発法人産業技術総合研究所 | 2024-08-15 | — | — | WO | disclosed |
| CN-105985774-B | The application of nanocrystalline-ligand complex, preparation method, printing material and printing material | 纳晶科技股份有限公司 | 2019-05-28 | — | — | CN | disclosed |
| CN-105985774-A | Nanocrystalline-ligand compound, preparation method of nanocrystalline-ligand compound, printing material and use of printing material | 纳晶科技股份有限公司 | 2016-10-05 | — | — | CN | disclosed |
| US-20160244464-A1 | SUBSTITUTED BENZENE COMPOUNDS | Epizyme, Inc. | 2016-08-25 | — | — | US | disclosed |
| US-20150344459-A1 | 1,4-PYRIDONE BICYCLIC HETEROARYL COMPOUNDS | Epizyme, Inc. | 2015-12-03 | — | — | US | disclosed |
| US-9045477-B2 | Substituted 6,5-fused bicyclic heteroaryl compounds | Epizyme, Inc. (US) | 2015-06-02 | — | — | US | disclosed |
| US-20140296283-A1 | Substituted 6,5-Fused Bicyclic Heteroaryl Compounds | Epizyme, Inc. (US) | 2014-10-02 | — | — | US | disclosed |
| US-8828996-B2 | Morpholine-spirocyclic piperidine amides as modulators of ion channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-09-09 | — | — | US | disclosed |
| EP-1209166-A1 | NOVEL A-500359 DERIVATIVES | Sankyo Company, Limited (JP) | 2002-05-29 | — | — | EP | disclosed |
| US-5691319-A | ANTICARCINOGENIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-11-25 | — | — | US | disclosed |
| US-5614550-A | ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| EP-0536936-B1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | SANKYO CO (JP) | 1996-08-14 | — | — | EP | disclosed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | disclosed |
| EP-0632036-A2 | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1995-01-04 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |
| CN-1042153-A | 3-aryloxy methyl-cephalosporins derivatives, their preparation and purposes pharmaceutically | SANKYO CO (JP) | 1990-05-16 | — | — | CN | disclosed |
| US-4369181-A | Process for treating proliferative skin diseases using certain 6,8-substituted ribofuranosylpurine-3',5'-cyclic phosphates | SRI INTERNATIONAL (US) | 1983-01-18 | — | — | US | disclosed |